Computational approaches in target identification and drug discovery

Computational and Structural Biotechnology Journal

Volumn 14, Issue , 2016, Pages 177-184

  Katsila, Theodora ^a   Spyroulias, Georgios A ^a   Patrinos, George P ^a,b   Matsoukas, Minos Timotheos ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Computer aided drug discovery; Data integration; Information technologies; Target identification

Indexed keywords

BIG DATA; COMPUTATIONAL METHODS; COST EFFECTIVENESS;

COMPUTATIONAL APPROACH; COMPUTATIONAL TOOLS; COMPUTER-AIDED DRUG DISCOVERY; DATA VOLUME; DRUG CANDIDATES; DRUG DISCOVERY; MECHANISM OF ACTION; OPEN DATUM; TARGET'S IDENTIFICATIONS; TECHNOLOGY DATA;

DATA INTEGRATION;

ARTICLE; CHEMOINFORMATICS; COMPUTER AIDED DESIGN; COST EFFECTIVENESS ANALYSIS; DRUG DESIGN; DRUG DEVELOPMENT; DRUG IDENTIFICATION; DRUG TARGETING; HIGH THROUGHPUT SCREENING; INFORMATION PROCESSING; INFORMATION SCIENCE; INFORMATION TECHNOLOGY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; SYSTEMS BIOLOGY; VALIDATION PROCESS;

EID: 84976421750     PISSN: None     EISSN: 20010370     Source Type: Journal    
DOI: 10.1016/j.csbj.2016.04.004     Document Type: Review

References (110)

1. A.-L. Barabási, N. Gulbahce, and J. Loscalzo Network medicine: a network-based approach to human disease Nat Rev Genet 12 2011 56 68
2. B. Chen, and A. Butte Network medicine in disease analysis and therapeutics Clin Pharmacol Ther 94 2013 627 629
3. E.P. Culligan, R.D. Sleator, J.R. Marchesi, and C. Hill Metagenomics and novel gene discovery: promise and potential for novel therapeutics Virulence 5 2014 399 412
4. K. Garber Drugging the gut microbiome Nat Biotechnol 33 2015 228 231
5. L. Wang, and X.-Q. Xie Computational target fishing: what should chemogenomics researchers expect for the future of in silico drug design and discovery? Future Med Chem 6 2014 247 249
6. D. Agrawal, P. Bernstein, E. Bertino, S. Davidson, U. Dayal, and et al. Challenges and opportunities with big data Proc VLDB Endowment 5 2012 2032 2033
7. G. Tsiliki, N. Karacapilidis, S. Christodoulou, and M. Tzagarakis Collaborative mining and interpretation of large-scale data for biomedical research insights PLoS One 9 2014 e108600
8. M.J. Keiser, V. Setola, J.J. Irwin, C. Laggner, A.I. Abbas, and et al. Predicting new molecular targets for known drugs Nature 462 2009 175 181
9. G.M. Nidhi, J.W. Davies, and J.L. Jenkins Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases J Chem Inf Model 46 2006 1124 1133
10. H. Li, Z. Gao, L. Kang, H. Zhang, K. Yang, and et al. TarFisDock: a web server for identifying drug targets with docking approach Nucleic Acids Res 34 2006 W219 W224
11. T. Cheng, Q. Li, Y. Wang, and S.H. Bryant Identifying compound-target associations by combining bioactivity profile similarity search and public databases mining J Chem Inf Model 51 2011 2440 2448
12. D. Rognan Theory and applications in computational chemistry: the first decade of the second millennium: International Congress TACC-2012 vol. 1456 2012 AIP Publishing 157 164
13. D. Rognan Structure-based approaches to target fishing and ligand profiling Mol Inf 29 2010 176 187
14. R. Cao, and Y. Wang Predicting molecular targets for small-molecule drugs with a ligand-based interaction fingerprint approach ChemMedChem 2015 [ePub ahead of print]
15. I. Eberini, S. Daniele, C. Parravicini, C. Sensi, M.L. Trincavelli, and et al. In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases J Comput Aided Mol Des 25 2011 743 752
16. A.-L. Barabasi, N. Gulbahce, and J. Loscalzo Network medicine: a network-based approach to human disease Nat Rev Genet 12 2011 56 68
17. H. Billur Engin, A. Gursoy, R. Nussinov, and O. Keskin Network-based strategies can help mono-and poly-pharmacology drug discovery: a systems biology view Curr Pharm Des 20 2014 1201 1207
18. S. Zhao, and S. Li Network-based relating pharmacological and genomic spaces for drug target identification PLoS One 5 2010 e11764
19. X. Wang, X. Wei, B. Thijssen, J. Das, S.M. Lipkin, and et al. Three-dimensional reconstruction of protein networks provides insight into human genetic disease Nat Biotechnol 30 2012 159 164
20. N.S. Buchan, D.K. Rajpal, Y. Webster, C. Alatorre, R.C. Gudivada, and et al. The role of translational bioinformatics in drug discovery Drug Discov Today 16 2011 426 434
21. A.J. Gentles, and D. Gallahan Systems biology: confronting the complexity of cancer Cancer Res 71 2011 5961 5964
22. D.S. Wishart, T. Jewison, A.C. Guo, M. Wilson, C. Knox, and et al. HMDB 3.0 - the human metabolome database in 2013 Nucleic Acids Res 41 2013 D801 D807
23. J. Xia, I.V. Sinelnikov, B. Han, and D.S. Wishart MetaboAnalyst 3.0 - making metabolomics more meaningful Nucleic Acids Res 43 2015 W251 W257
24. P. Creixell, E.M. Schoof, C.D. Simpson, J. Longden, C.J. Miller, and et al. Kinome-wide decoding of network-attacking mutations rewiring cancer signaling Cell 163 2015 202 217
25. J. Lamb, E.D. Crawford, D. Peck, J.W. Modell, I.C. Blat, and et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease Science 313 2006 1929 1935
26. J. Lamb The connectivity map: a new tool for biomedical research Nat Rev Cancer 7 2007 54 60
27. F.M. Alakwaa, N.H. Solouma, and Y.M. Kadah Construction of gene regulatory networks using biclustering and bayesian networks Theor Biol Med Model 8 2011 39
28. L.M. Heiser, N.J. Wang, C.L. Talcott, K.R. Laderoute, M. Knapp, and et al. Integrated analysis of breast cancer cell lines reveals unique signaling pathways Genome Biol 10 2009 R31
29. E. Yeger-Lotem, L. Riva, L.J. Su, A.D. Gitler, A.G. Cashikar, and et al. Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity Nat Genet 41 2009 316 323
30. C. Stark, B.-J. Breitkreutz, T. Reguly, L. Boucher, A. Breitkreutz, and et al. BioGRID: a general repository for interaction datasets Nucleic Acids Res 34 2006 D535 D539
31. B.-J. Breitkreutz, C. Stark, and M. Tyers Osprey: a network visualization system Genome Biol 4 2003 R22
32. P. Shannon, A. Markiel, O. Ozier, N.S. Baliga, J.T. Wang, and et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks Genome Res 13 2003 2498 2504
33. J.M. Guberman, J. Ai, O. Arnaiz, J. Baran, A. Blake, and et al. BioMart central portal: an open database network for the biological community. Database 2011: bar041 2011
34. D.R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, and et al. ONCOMINE: a cancer microarray database and integrated data-mining platform Neoplasia 6 2004 1 6
35. C. Douville, H. Carter, R. Kim, N. Niknafs, M. Diekhans, and et al. CRAVAT: cancer-related analysis of variants toolkit Bioinformatics 29 2013 647 648
36. N.-L. Sim, P. Kumar, J. Hu, S. Henikoff, G. Schneider, and et al. SIFT web server: predicting effects of amino acid substitutions on proteins Nucleic Acids Res 40 2012 W452 W457
37. Y. Choi, and A.P. Chan PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels Bioinformatics 31 2015 2745 2747
38. D. Grapov, K. Wanichthanarak, and O. Fiehn MetaMapR: pathway independent metabolomic network analysis incorporating unknowns Bioinformatics 31 2015 2757 2760
39. W. Humphrey, A. Dalke, and K. Schulten VMD: visual molecular dynamics J Mol Graph 14 1996 33 38
40. E.F. Pettersen, T.D. Goddard, C.C. Huang, G.S. Couch, D.M. Greenblatt, and et al. UCSF chimera - a visualization system for exploratory research and analysis J Comput Chem 25 2004 1605 1612
41. J. Lonsdale, J. Thomas, M. Salvatore, R. Phillips, E. Lo, and et al. The genotype-tissue expression (GTEx) project Nat Genet 45 2013 580 585
42. R. Thompson, L. Johnston, D. Taruscio, L. Monaco, C. Béroud, and et al. RD-connect: an integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research J Gen Intern Med 29 2014 780 787
43. Y. Zhang, C. Tao, G. Jiang, A.A. Nair, J. Su, and et al. Network-based analysis reveals distinct association patterns in a semantic MEDLINE-based drug-disease-gene network J Biomed Semant 5 2014 1 13
44. A. Peter Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility Nat Commun 6 2015
45. R. Barrangou, A. Birmingham, S. Wiemann, R.L. Beijersbergen, V. Hornung, and et al. Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference Nucleic Acids Res 43 2015 3407 3419
46. B. Chen, and A.J. Butte Leveraging big data to transform target selection and drug discovery Clin Pharmacol Ther 99 2015 285 297
47. T.N. Doman, S.L. McGovern, B.J. Witherbee, T.P. Kasten, R. Kurumbail, and et al. Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B J Med Chem 45 2002 2213 2221
48. J.S. Sawyer, B.D. Anderson, D.W. Beight, R.M. Campbell, M.L. Jones, and et al. Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-β type i receptor kinase domain J Med Chem 46 2003 3953 3956
49. J. Singh, C.E. Chuaqui, P.A. Boriack-Sjodin, W.-C. Lee, T. Pontz, and et al. Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI) Bioorg Med Chem Lett 13 2003 4355 4359
50. C. Shekhar In silico pharmacology: computer-aided methods could transform drug development Chem Biol 15 2008 413 414
51. O.-Y. S-s, J.-y. Lu, X.-q. Kong, Z.-j. Liang, C. Luo, and et al. Computational drug discovery Acta Pharmacol Sin 33 2012 1131 1140
52. G. Sliwoski, S. Kothiwale, J. Meiler, and E.W. Lowe Computational methods in drug discovery Pharmacol Rev 66 2014 334 395
53. J.J. Irwin, T. Sterling, M.M. Mysinger, E.S. Bolstad, and R.G. Coleman ZINC: a free tool to discover chemistry for biology J Chem Inf Model 52 2012 1757 1768
54. S. Kim, P.A. Thiessen, E.E. Bolton, J. Chen, G. Fu, and et al. Pubchem substance and compound databases Nucleic Acids Res 44 2015 D1202 D1213
55. R. Kurczab, M. Nowak, Z. Chilmonczyk, I. Sylte, and A.J. Bojarski The development and validation of a novel virtual screening cascade protocol to identify potential serotonin 5-HT7R antagonists Bioorg Med Chem Lett 20 2010 2465 2468
56. C. de Graaf, C. Rein, D. Piwnica, F. Giordanetto, and D. Rognan Structure-based discovery of allosteric modulators of two related class B G-protein-coupled receptors ChemMedChem 6 2011 2159 2169
57. Q. Zhang, and I. Muegge Scaffold hopping through virtual screening using 2d and 3d similarity descriptors: ranking, voting, and consensus scoring J Med Chem 49 2006 1536 1548
58. T. Ramasamy, and C. Selvam Performance evaluation of structure based and ligand based virtual screening methods on ten selected anti-cancer targets Bioorg Med Chem Lett 25 2015 4632 4636
59. M.N. Drwal, and R. Griffith Combination of ligand- and structure-based methods in virtual screening Drug Discov Today: Technol 10 2013 e395 e401
60. Z. Chen, G. Tian, Z. Wang, H. Jiang, J. Shen, and et al. Multiple pharmacophore models combined with molecular docking: a reliable way for efficiently identifying novel PDE4 inhibitors with high structural diversity J Chem Inf Model 50 2010 615 625
61. J. Meslamani, J. Li, J. Sutter, A. Stevens, H.-O. Bertrand, and et al. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling J Chem Inf Model 52 2012 943 955
62. E.L. Leung, Z.-W. Cao, Z.-H. Jiang, H. Zhou, and L. Liu Network-based drug discovery by integrating systems biology and computational technologies Brief Bioinform 14 2013 491 505
63. X. Liu, F. Zhu, X. H. Ma, Z. Shi, S. Y. Yang, and et al. Predicting targeted polypharmacology for drug repositioning and multi- target drug discovery Curr Med Chem 20 2013 1646 1661
64. J. Kaiser Combining targeted drugs to stop resistant tumors Science 331 2011 1542 1545
65. D. Stumpfe, P. Ripphausen, and J. Bajorath Virtual compound screening in drug discovery Future Med Chem 4 2012 593 602
66. J. Auer, and J. Bajorath J. Keith, Bioinformatics 2008 Humana Press 327 347
67. E. Bourinet, and G.W. Zamponi Voltage gated calcium channels as targets for analgesics Curr Top Med Chem 5 2005 539 546
68. I. Ijjaali, C. Barrere, J. Nargeot, F. Petitet, and E. Bourinet Ligand-based virtual screening to identify new T-type calcium channel blockers Channels 1 2007 300 304
69. S. Zhang S.D. Satyanarayanajois, Drug design and discovery 2011 Humana Press 23 38
70. F. Gasparini, G. Bilbe, B. Gomez-Mancilla, and W. Spooren mGluR5 antagonists: discovery, characterization and drug development Curr Opin Drug Discov Devel 11 2008 655 665
71. A.L. Rodriguez, M.D. Grier, C.K. Jones, E.J. Herman, A.S. Kane, and et al. Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity Mol Pharmacol 78 2010 1105 1123
72. R. Mueller, A.L. Rodriguez, E.S. Dawson, M. Butkiewicz, T.T. Nguyen, and et al. Identification of metabotropic glutamate receptor subtype 5 potentiators using virtual high-throughput screening ACS Chem Neurosci 1 2010 288 305
73. I. Cortes-Ciriano, Q.U. Ain, V. Subramanian, E.B. Lenselink, O. Mendez-Lucio, and et al. Polypharmacology modelling using proteochemometrics (PCM): recent methodological developments, applications to target families, and future prospects Med Chem Commun 6 2015 24 50
74. M. Lapinsh, P. Prusis, A. Gutcaits, T. Lundstedt, and J.E.S. Wikberg Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions Biochim Biophys Acta 1525 2001 180 190
75. G.J.P. van Westen, J.K. Wegner, A.P. Ijzerman, H.W.T. van Vlijmen, and A. Bender Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets Med Chem Commun 2 2011 16 30
76. T.M. Frimurer, T. Ulven, C.E. Elling, L.-O. Gerlach, E. Kostenis, and et al. A physicogenetic method to assign ligand-binding relationships between 7TM receptors Bioorg Med Chem Lett 15 2005 3707 3712
77. J. Wang, R.M. Wolf, J.W. Caldwell, P.A. Kollman, and D.A. Case Development and testing of a general amber force field J Comput Chem 25 2004 1157 1174
78. K. Vanommeslaeghe, E. Hatcher, C. Acharya, S. Kundu, S. Zhong, and et al. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields J Comput Chem 31 2010 671 690
79. W. Liu, B. Schmidt, G. Voss, and W. Müller-Wittig Accelerating molecular dynamics simulations using graphics processing units with CUDA Comput Phys Commun 179 2008 634 641
80. Y. Shan, E.T. Kim, M.P. Eastwood, R.O. Dror, M.A. Seeliger, and et al. How does a drug molecule find its target binding site? J Am Chem Soc 133 2011 9181 9183
81. T. Hou, J. Wang, Y. Li, and W. Wang Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations J Chem Inf Model 51 2010 69 82
82. T. Hansson, J. Marelius, and J. Åqvist Ligand binding affinity prediction by linear interaction energy methods J Comput Aided Mol Des 12 1998 27 35
83. 3 in the gas phase J Am Chem Soc 109 1987 1607 1614
84. J. Wang, P. Morin, W. Wang, and P.A. Kollman Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA J Am Chem Soc 123 2001 5221 5230
85. S. Miyamoto, and P.A. Kollman Absolute and relative binding free energy calculations of the interaction of biotin and its analogs with streptavidin using molecular dynamics/free energy perturbation approaches Proteins Struct Funct Genet 16 1993 226 245
86. B.A. Tounge, R. Rajamani, E.W. Baxter, A.B. Reitz, and C.H. Reynolds Linear interaction energy models for β-secretase (BACE) inhibitors: role of van der Waals, electrostatic, and continuum-solvation terms J Mol Graph Model 24 2006 475 484
87. N. Eswar, B. Webb, M.A. Marti-Renom, M.S. Madhusudhan, D. Eramian, and et al. Current protocols in protein science 2006 5.6. 1 5.6. 30
88. T. Schwede, J. Kopp, N. Guex, and M.C. Peitsch SWISS-MODEL: an automated protein homology-modeling server Nucleic Acids Res 31 2003 3381 3385
89. B. Wu, E.Y.T. Chien, C.D. Mol, G. Fenalti, W. Liu, and et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists Science 330 2010 1066 1071
90. S. Blättermann, L. Peters, P.A. Ottersbach, A. Bock, V. Konya, and et al. A biased ligand for OXE-R uncouples Gα and Gβγ signaling within a heterotrimer Nat Chem Biol 8 2012 631 638
91. M.-T. Matsoukas, A. Cordomí, S. Ríos, L. Pardo, and T. Tselios Ligand binding determinants for angiotensin II type 1 receptor from computer simulations J Chem Inf Model 53 2013 2874 2883
92. H. Zhang, H. Unal, C. Gati, W. Han Gye, W. Liu, and et al. Structure of the angiotensin receptor revealed by serial femtosecond crystallography Cell 161 2015 833 844
93. E. Yuriev, M. Agostino, and P.A. Ramsland Challenges and advances in computational docking: 2009 in review J Mol Recognit 24 2011 149 164
94. M.L. Verdonk, J.C. Cole, M.J. Hartshorn, C.W. Murray, and R.D. Taylor Improved protein-ligand docking using GOLD Proteins Struct Funct Bioinf 52 2003 609 623
95. G.M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, and et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility J Comput Chem 30 2009 2785 2791
96. O. Trott, and A.J. Olson AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading J Comput Chem 31 2010 455 461
97. D. Moustakas, P.T. Lang, S. Pegg, E. Pettersen, I. Kuntz, and et al. Development and validation of a modular, extensible docking program: DOCK 5 J Comput Aided Mol Des 20 2006 601 619
98. R.A. Friesner, R.B. Murphy, M.P. Repasky, L.L. Frye, J.R. Greenwood, and et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes J Med Chem 49 2006 6177 6196
99. A.N. Jain Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine J Med Chem 46 2003 499 511
100. D.R. Houston, and M.D. Walkinshaw Consensus docking: improving the reliability of docking in a virtual screening context J Chem Inf Model 53 2013 384 390
101. T. Tuccinardi, G. Poli, V. Romboli, A. Giordano, and A. Martinelli Extensive consensus docking evaluation for ligand pose prediction and virtual screening studies J Chem Inf Model 54 2014 2980 2986
102. G. Wolber, and T. Langer LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters J Chem Inf Model 45 2005 160 169
103. J. Chen, and L. Lai Pocket v.2: further developments on receptor-based pharmacophore modeling J Chem Inf Model 46 2006 2684 2691
104. A.C. Pierce, M. Jacobs, and C. Stuver-Moody Docking study yields four novel inhibitors of the protooncogene pim-1 kinase J Med Chem 51 2008 1972 1975
105. B.K. Allen, S. Mehta, S.W.J. Ember, E. Schonbrunn, N. Ayad, and et al. Large-scale computational screening identifies first in class multitarget inhibitor of EGFR kinase and BRD4 Sci Rep 5 2015 16924
106. M.-T. Matsoukas, Á. Aranguren-Ibáñez, T. Lozano, V. Nunes, J.J. Lasarte, and et al. Identification of small-molecule inhibitors of calcineurin-NFATc signaling that mimic the PxIxIT motif of calcineurin binding partners Sci Signal 8 2015 ra63
107. J.-L. Reymond, and M. Awale Exploring chemical space for drug discovery using the chemical universe database ACS Chem Neurosci 3 2012 649 657
108. A. Kumar, A. Voet, and K.Y.J. Zhang Fragment based drug design: from experimental to computational approaches Curr Med Chem 19 2012 5128 5147
109. Y. Cheng, T.C. Judd, M.D. Bartberger, J. Brown, K. Chen, and et al. From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) J Med Chem 54 2011 5836 5857
110. S.J. Hughes, D.S. Millan, I.C. Kilty, R.A. Lewthwaite, J.P. Mathias, and et al. Fragment based discovery of a novel and selective PI3 kinase inhibitor Bioorg Med Chem Lett 21 2011 6586 6590